Granules gets USFDA nod for sleep aid drug
Granules India announced that the US Food & Drug Administration (US FDA) has approved its abbreviated new drug application (ANDA) for naproxen...
Zydus Cadila & Cipla gets USFDA nod for dimethyl fumarate DR capsules
Zydus Cadila
Zydus Cadila has received final approval from the USFDA to market dimethyl fumarate delayed-release capsules, (US...
Sun Pharma recalls metformin due to high NDMA levels
Sun Pharmaceutical Industries is voluntarily recalling one lot of RIOMET ER (metformin hydrochloride for extended-release oral suspension), 500 mg per 5 mL...
Zydus Cadila gets tentative USFDA nod for anti-cancer drug
Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules.
Sun Pharma launches ILUMYA – Tildrakizumab
Sun Pharmaceutical Industries announced that its wholly-owned Japanese subsidiary has launched ILUMYA subcutaneous injection 100 mg syringe (nonproprietary name: tildrakizumab) in Japan...
Strides Pharma gets USFDA nod for tension headache tablets
NEW DELHI: Drug firm Strides Pharma Science on Tuesday said its subsidiary, Strides Pharma Global Pte Ltd, has received approval from the US health...
Lupin launches divalproex sodium ER tablets
Lupin announced the launch of divalproex sodium extended-release (ER) tablets USP, 250 mg and 500 mg, having received an approval from the...
BDR Pharma launches 80mg of Enzalutamide for prostate cancer
BDR Pharmaceutical has launched 80mg advanced version of its Enzalutamide drug. Earlier the company had received the approval from the Drugs Controller...
Zydus Cadila gets USFDA nod for mineral supplement
Zydus Cadila has received final approval from the USFDA to market potassium chloride extended-release tablets (US RLD: K-Dur Extended-Release Tablets) in the...
Dr Reddy’s launches OTC Ophthalmic Solution
Dr Reddy’s Laboratories announced the launch of over-the-counter (OTC) Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the store brand equivalents of...
Indoco gets USFDA nod for Apixaban tablets
Indoco Remedies announced receipt of approval from USFDA for its ANDA for Apixaban Tablets 2.5 mg and 5 mg. The products are...
Granules gets USFDA nod for dexmethylphenidate HCl extended-release capsules
Granules announced its US subsidiary has received marketing approval from the US FDA for Dexmethylphenidate HCl extended-release capsules for the treatment of...
Zydus Cadila gets USFDA nod for Doxorubicin HCL Liposome Injection
Zydus Cadila has received final approval from the USFDA to market Doxorubicin Hydrochloride Liposome Injection (US RLD: Doxil Liposome Injection) in the...
Cadila launches generic obeticholic acid for liver therapy
Cadila Pharma announced the launch of generic Obeticholic Acid (Ocaliva), a generic version of Ocaliva (Obeticholic Acid), in India. The molecule is...
Zydus Cadila gets tentative nod for generic diabetes drug
New Delhi: Drug firm Zydus Cadila on Wednesday said it has received approval from the US health regulator to market diabetes drug, Empagliflozin and Linagliptin tablets, in the US...
Dr Reddy’s Lab launches Fulvestrant Inj
Dr Reddy’s Laboratories announced the launch of Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version...
Alembic Pharma gets tentative USFDA nod for Treprostinil Inj
Alembic Pharma announced that its wholly-owned subsidiary Alembic Global Holdings SA has received tentative approval from the US Food & Drug Administration...
Lilly gets USFDA nod for additional doses type 2 diabetes
The US Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company’s Trulicity (dulaglutide). The approval expands the...
Roche, Blueprint lung cancer drug wins FDA approval
Roche Holding AG on Friday said a therapy it co-developed with Cambridge-based Blueprint Medicines Corp was approved by the U.S. health regulator for the treatment of patients...
BDR Pharma to launch 400 mg Favipiravir tablets
BDR Pharmaceuticals said it plans to launch 400 mg Favipiravir tablets, used for treating COVID-19 patients, in the country.
The...
Authors
